What is the vesting schedule and performance conditions (if any) attached to the RSUs?

Vesting schedule & performance conditions

The filing only states that Schröding er, Inc. granted 1,875 restricted‑stock units (RSUs) to two newly hired employees on August 15 2025 under the 2021 Inducement Equity Incentive Plan. The release does not disclose any specific vesting timetable or performance‑based criteria for those RSUs. In the absence of explicit terms, the grants are presumed to follow the company’s standard inducement‑RSU structure, which typically consists of a time‑based vesting schedule (e.g., 25 % per year over a 4‑year period) and no additional performance hurdles beyond continued employment.

Trading implications

Because the vesting terms are not material to the current share supply and there are no performance conditions that could trigger accelerated dilution, the market impact of this particular grant is minimal. The issuance represents a modest 1,875‑share allocation—well below the daily float for SDGR—so it is unlikely to affect liquidity or price action in the short term. Traders can therefore keep the focus on broader fundamentals (e.g., Schröding er’s drug pipeline, cash position, and upcoming earnings) and technical momentum, rather than expecting any immediate volatility from this RSU grant.